Logo image of CPZ

CALAMOS LNG/SHRT EQTY & DYN (CPZ) Stock Price, Quote, News and Overview

NASDAQ:CPZ - Nasdaq - US12812C1062 - Currency: USD

16.15  -0.04 (-0.25%)

Fundamental Rating

2

CPZ gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. CPZ may be in some trouble as it scores bad on both profitability and health. CPZ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CPZ was profitable.
In the past year CPZ had a positive cash flow from operations.
In multiple years CPZ reported negative net income over the last 5 years.
In multiple years CPZ reported negative operating cash flow during the last 5 years.
CPZ Yearly Net Income VS EBIT VS OCF VS FCFCPZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

Industry RankSector Rank
ROA 7.33%
ROE 16.2%
ROIC 7.47%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CPZ Yearly ROA, ROE, ROICCPZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

In the last couple of years the Profit Margin of CPZ has declined.
In the last couple of years the Operating Margin of CPZ has declined.
CPZ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 79.52%
PM (TTM) 63.43%
GM 83.76%
OM growth 3Y-2.36%
OM growth 5YN/A
PM growth 3Y-26.09%
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5YN/A
CPZ Yearly Profit, Operating, Gross MarginsCPZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

More info and screens

0

2. Health

2.1 Basic Checks

There is no outstanding debt for CPZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CPZ Yearly Shares OutstandingCPZ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M
CPZ Yearly Total Debt VS Total AssetsCPZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.37, we must say that CPZ is in the distress zone and has some risk of bankruptcy.
CPZ has a debt to FCF ratio of 6.13. This is a slightly negative value and a sign of low solvency as CPZ would need 6.13 years to pay back of all of its debts.
A Debt/Equity ratio of 1.13 is on the high side and indicates that CPZ has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 6.13
Altman-Z 0.37
ROIC/WACCN/A
WACCN/A
CPZ Yearly LT Debt VS Equity VS FCFCPZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

CPZ has a Current Ratio of 0.11. This is a bad value and indicates that CPZ is not financially healthy enough and could expect problems in meeting its short term obligations.
CPZ has a Quick Ratio of 0.11. This is a bad value and indicates that CPZ is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11
CPZ Yearly Current Assets VS Current LiabilitesCPZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 371.43% over the past year.
The earnings per share for CPZ have been decreasing by -22.75% on average. This is quite bad
CPZ shows a strong growth in Revenue. In the last year, the Revenue has grown by 69.70%.
CPZ shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.20% yearly.
EPS 1Y (TTM)371.43%
EPS 3Y-22.75%
EPS 5YN/A
EPS Q2Q%212.82%
Revenue 1Y (TTM)69.7%
Revenue growth 3Y5.2%
Revenue growth 5YN/A
Sales Q2Q%82.58%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CPZ Yearly Revenue VS EstimatesCPZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.12, which indicates a rather cheap valuation of CPZ.
CPZ is valuated cheaply when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.12
Fwd PE N/A
CPZ Price Earnings VS Forward Price EarningsCPZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 5.28
EV/EBITDA N/A
CPZ Per share dataCPZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.72%, CPZ is a good candidate for dividend investing.
CPZ's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 10.72%

5.2 History

CPZ has been paying a dividend for over 5 years, so it has already some track record.
As CPZ did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years5
CPZ Yearly Dividends per shareCPZ Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CPZ pays out 62.68% of its income as dividend. This is not a sustainable payout ratio.
DP62.68%
EPS Next 2YN/A
EPS Next 3YN/A
CPZ Yearly Income VS Free CF VS DividendCPZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 100M -100M -200M -300M
CPZ Dividend Payout.CPZ Dividend Payout, showing the Payout Ratio.CPZ Dividend Payout.PayoutRetained Earnings

More info and screens

CALAMOS LNG/SHRT EQTY & DYN

NASDAQ:CPZ (7/29/2025, 10:29:40 AM)

16.15

-0.04 (-0.25%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners51.81%
Inst Owner Change-0.23%
Ins Owners0.73%
Ins Owner Change-334.79%
Market Cap317.02M
Analysts0
Price TargetN/A
Short Float %0.32%
Short Ratio0.93
Dividend
Industry RankSector Rank
Dividend Yield 10.72%
Yearly Dividend1.68
Dividend Growth(5Y)N/A
DP62.68%
Div Incr Years1
Div Non Decr Years5
Ex-Date07-14 2025-07-14 (0.14)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.12
Fwd PE N/A
P/S 3.82
P/FCF 5.28
P/OCF 5.28
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)2.64
EY16.35%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.06
FCFY18.93%
OCF(TTM)3.06
OCFY18.93%
SpS4.23
BVpS16.56
TBVpS16.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.33%
ROE 16.2%
ROCE 14.67%
ROIC 7.47%
ROICexc 7.52%
ROICexgc 7.53%
OM 79.52%
PM (TTM) 63.43%
GM 83.76%
FCFM 72.29%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.36%
OM growth 5YN/A
PM growth 3Y-26.09%
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5YN/A
F-Score6
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 6.13
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 9.24
Cash Conversion N/A
Profit Quality 113.96%
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z 0.37
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)371.43%
EPS 3Y-22.75%
EPS 5YN/A
EPS Q2Q%212.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)69.7%
Revenue growth 3Y5.2%
Revenue growth 5YN/A
Sales Q2Q%82.58%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y99.52%
EBIT growth 3Y2.72%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-49.81%
FCF growth 3Y-18.22%
FCF growth 5YN/A
OCF growth 1Y-49.81%
OCF growth 3Y-18.22%
OCF growth 5YN/A